Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hoge, C. W.
Right arrow Articles by Kitporka, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoge, C. W.
Right arrow Articles by Kitporka, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 143, No. 3: 263-268
Copyright © 1996 by The Johns Hopkins University School of Hygiene and Public Health


research-article

Epidemiologic Study of Vibrio cholerae O1 and O139 in Thailand: At the Advancing Edge of the Eighth Pandemic

Charles W. Hoge1,, Ladapom Bodhidatta1, Peter Echeverria1, Mantana Deesuwan2 and Paisal Kitporka2

1Department of Bacteriology, Immunology, and Molecular Genetics, Armed Forces Research Institute of Medical Sciences Bangkok, Thailand
2Samutsakom Hospital Samutsakom, Thailand

Reprint requests to Dr. Charles W. Hoge, Department of Enteric Infections, Division of Communicable Diseases and Immunology, Walter Reed Army Institute of Research, Building 40, 14th and Dahlia Streets NW, Washington, DC 20307–5100

Vibrio cholerae O139 Bengal emerged on the Indian subcontinent in late 1992 and was first recognized in Thailand in 1993. To characterize the epidemiology of this disease, a hospital-based case-control study was conducted in Samutsakorn, a port city 30 km southwest of Bangkok. Between November 15, 1993, and June 3, 1994, 366 patients were confirmed to have cholera by culture, including 165 (45%) with O139 Bengal, 191 (52%) with O1 Ogawa, and 10 (3%) with both serogroups. During the same time period the previous year, 319 culture-confirmed cholera cases occurred, all serogroup O1. Questionnaires were obtained from 105 patients with O139 Bengal and 103 with O1 infections; for each case patient, two asymptomatic age- and sex-matched control persons were selected. Of the patients with O139 Bengal infections, 93% were adults (≥15 years) compared with 92% of patients with O1 infections. Risk factors for cholera identified by case-control comparisons were similar for the two serogroups and included consumption of untreated water, uncooked seafood, and food served at group gatherings. V. cholerae O139 Bengal has emerged in Thailand as a cause of endemic cholera, with epidemiologic features and incidence similar to those of the preexisting O1 strain.

cholera; epidemiologic factors; risk factors; Vibrio cholerae; Vibrio infections


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am J Trop Med HygHome page
G. P. RICHARDS and M. A. WATSON
A simple fluorogenic method to detect Vibrio cholerae and Aeromonas hydrophila in well water for areas impacted by catastrophic disasters.
Am J Trop Med Hyg, September 1, 2006; 75(3): 516 - 521.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
A. Dalsgaard, A. Forslund, D. Sandvang, L. Arntzen, and K. Keddy
Vibrio cholerae O1 outbreak isolates in Mozambique and South Africa in 1998 are multiple-drug resistant, contain the SXT element and the aadA2 gene located on class 1 integrons
J. Antimicrob. Chemother., December 1, 2001; 48(6): 827 - 838.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
K. H. Chow, T. K. Ng, K. Y. Yuen, and W. C. Yam
Detection of RTX Toxin Gene in Vibrio cholerae by PCR
J. Clin. Microbiol., July 1, 2001; 39(7): 2594 - 2597.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. L. Chiang and J. J. Mekalanos
Construction of a Vibrio cholerae Vaccine Candidate Using Transposon Delivery and FLP Recombinase-Mediated Excision
Infect. Immun., November 1, 2000; 68(11): 6391 - 6397.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Z. Kossaczka, J. Shiloach, V. Johnson, D. N. Taylor, R. A. Finkelstein, J. B. Robbins, and S. C. Szu
Vibrio cholerae O139 Conjugate Vaccines: Synthesis and Immunogenicity of V. cholerae O139 Capsular Polysaccharide Conjugates with Recombinant Diphtheria Toxin Mutant in Mice
Infect. Immun., September 1, 2000; 68(9): 5037 - 5043.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. Dalsgaard, A. Forslund, N. V. Tam, D. X. Vinh, and P. D. Cam
Cholera in Vietnam: Changes in Genotypes and Emergence of Class I Integrons Containing Aminoglycoside Resistance Gene Cassettes in Vibrio cholerae O1 Strains Isolated from 1979 to 1996
J. Clin. Microbiol., March 1, 1999; 37(3): 734 - 741.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.